Porton Advanced Solutions Completes a Series B Financing Round to Expand its end-to-end Gene and Cell Therapy CDMO Platforms
Porton Advanced Solutions announced the completion of its Series B financing round with over US$80Million. Current round of financing was led by China Merchants Groups’Â healthcare PE fund Merchant Health, along with its sister fund China Merchants Capital, China Merchants Securities Investments. In addition, a number of renowned venture and private......